MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517042861 A) filed by Institute Of Materia Medica, Chinese Academy Of Medical Sciences, Beijing, on May 2, for 'keratin yk93-4, and preparation method therefor, pharmaceutical composition thereof and use thereof.'
Inventor(s) include Yu, Shishan; Chen, Xiaoguang; Liu, Yunbao; Jin, Jing; Li, Mi; Qu, Jing; Hao, Mengyao; Wang, Xiaojing; Li, Yong; Wang, Mingjin; Shi, Guoru; Ma, Shuanggang; Jiang, Huimin; Fu, Jiang; and Li, Shuying.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "The present invention belongs to the field of biopharmaceuticals. Provided in the present invention are keratin YK93-4, a nucleic acid molecule encoding same, an expression vector containing the nucleic acid molecule, a host cell containing the expression vector or a host cell having the nucleic acid molecule integrated into the genome, as well as a method for preparing keratin YK93-4 and a pharmaceutical composition of keratin YK93-4. Further provided is the use of the above-described keratin YK93-4 and related products thereof in the preparation of drugs for treating lung cancer, lymphoma, breast cancer, melanoma, uterus myoma, hyperplasia of prostate, etc."
The patent application was internationally filed on Sept. 26, 2023, under International application No.PCT/CN2023/121583.
Disclaimer: Curated by HT Syndication.
